Skip to main content

Animations

MJFF Publications

1771 - 1780 of 8399 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • RESTRICTED
    Title: Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41594-022-00837-0
    Best OA location URL:
    Citation Count: 37
  • OPEN
    Title: Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control Study
    Journal Name: Clinical Epidemiology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.2147/clep.s381289
    Citation Count: 9
  • RESTRICTED
    Title: Issue Overview
    Journal Name: CONTINUUM: Lifelong Learning in Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/01.con.0000892540.33029.c0
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Mechanisms controlling selective elimination of damaged lysosomes
    Journal Name: Current Opinion in Physiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.cophys.2022.100590
    Citation Count: 21
  • RESTRICTED
    Title: Mechanisms of NLRP3 activation and pathology during neurodegeneration
    Journal Name: The International Journal of Biochemistry & Cell Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.biocel.2022.106273
    Best OA location URL:
    Citation Count: 10
  • RESTRICTED
    Title: Neurodegenerative Cerebellar Ataxia
    Journal Name: CONTINUUM: Lifelong Learning in Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/con.0000000000001180
    Best OA location URL:
    Citation Count: 6
  • OPEN
    Title: Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina
    Journal Name: Journal of Extracellular Biology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/jex2.59
    Citation Count: 104
  • RESTRICTED
    Title: Prodromal α-Synucleinopathies
    Journal Name: CONTINUUM: Lifelong Learning in Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/con.0000000000001153
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: A systematic review and meta-analysis
    Journal Name: Cytokine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cyto.2022.156006
    Citation Count: 25
  • RESTRICTED
    Title: Triplication of Synaptojanin 1 in Alzheimer’s Disease Pathology in Down Syndrome
    Journal Name: Current Alzheimer Research
    Publisher: Bentham Science Publishers Ltd.
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2174/1567205020666221202102832
    Best OA location URL:
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.